AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Carlat Psychiatry Podcast
Auvelity A Fast Acting Antidepressant
Feb 5, 2024
Dr. Aiken and Kellie discuss Auvelity, a fast-acting antidepressant, exploring its pharmacodynamics, benefits of pairing with bupropion, and update on treatment-resistant depression trial. They also delve into Aveleti's efficacy in depression treatment and ongoing studies.
16:44
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Auvelity combines Bute-Proprion and Dex-Tromethorphin for faster relief from depression symptoms.
- Clinical trials show Auvelity's efficacy surpassing Bute-Proprion in reducing depression symptoms in the first week.
Deep dives
The Composition of Orvellaity
Orvellaity is a combination of two older medications, Bute-Proprion and Dex-Tromethorphin. Bute-Proprion is an orepinephrine and dopamine reuptake inhibitor, while Dex-Tromethorphin increases glutamate transmission through NMDA and tagganism, similar to other third-line interventions for treatment-resistant depression. Orvellaity is the first oral antidepressant to move beyond the traditional monoamine means of serotonin, norepinephrine, and dopamine.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode